Caffeine and the eye.


Journal

Survey of ophthalmology
ISSN: 1879-3304
Titre abrégé: Surv Ophthalmol
Pays: United States
ID NLM: 0404551

Informations de publication

Date de publication:
Historique:
received: 25 05 2018
revised: 14 10 2018
accepted: 15 10 2018
pubmed: 27 10 2018
medline: 28 12 2019
entrez: 27 10 2018
Statut: ppublish

Résumé

Caffeine, a popular psychostimulant that acts as an adenosine receptor antagonist, is the most widely used drug in history, consumed daily by people worldwide. Knowledge of the physiological and pathological effects of caffeine is crucial in improving public health because of its widespread use. We provide a summary of the current evidence on the effect of caffeine on the eye. Most of the research conducted to date is in relation to cataract and glaucoma, two of the most common eye diseases among the elderly.

Identifiants

pubmed: 30365973
pii: S0039-6257(18)30130-9
doi: 10.1016/j.survophthal.2018.10.005
pii:
doi:

Substances chimiques

Central Nervous System Stimulants 0
Caffeine 3G6A5W338E

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

334-344

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Jinny J Yoon (JJ)

Department of Ophthalmology, University of Auckland, New Zealand.

Helen V Danesh-Meyer (HV)

Department of Ophthalmology, University of Auckland, New Zealand. Electronic address: helendm@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH